Literature DB >> 1793728

Weekly oral 4-demethoxydaunorubicin in patients with relapsed low grade non-Hodgkin's lymphoma.

W P Steward1, D B Smith, D Crowther.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1793728     DOI： 10.1093/oxfordjournals.annonc.a058028

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

Review 1.  Oral idarubicin. A review of its pharmacological properties and clinical efficacy in the treatment of haematological malignancies and advanced breast cancer.

Authors:  M M Buckley; H M Lamb
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 2.  Oral idarubicin--an anthracycline derivative with unique properties.

Authors:  M Goebel
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

Review 3.  Potential role of oral anthracyclines in older patients with cancer.

Authors:  W S Lasota; D L de Valeriola; M J Piccart
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.